HomeInsightsResults

Suven Life Sciences Ltd Quarterly Result

Suven Life Sciences Ltd Quarterly Result

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

10.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Suven Life Sciences Ltd

NSE: SUVEN

Net Profit

₹ -49.64

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Suven Life Sciences Ltd for the Sep '24 is ₹ 6.61 crore as compare to the Jun '24 revenue of ₹ 5.01 crore. This represent the growth of 31.936123%.
  • The ebitda of Suven Life Sciences Ltd for the Sep '24 is ₹ -48.17 crore as compare to the Jun '24 ebitda of ₹ -26.53 crore. This represent the growth of 81.56802%.
  • The net profit of Suven Life Sciences Ltd for the Sep '24 is ₹ -49.64 crore as compare to the Jun '24 net profit of ₹ -28.04 crore. This represent the growth of 77.0328%.

Results Analysis

Market Price of Suven Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Suven Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024117.45
21 Nov 2024118.15
19 Nov 2024120.8
18 Nov 2024120.6
14 Nov 2024119.8
13 Nov 2024120.6
12 Nov 2024126.85
11 Nov 2024125.05
08 Nov 2024128.65
07 Nov 2024131.45

Historical Revenue of Suven Life Sciences Ltd

No data available

* All values are in crore

Historical EBITDA of Suven Life Sciences Ltd

No data available

* All values are in crore

Historical Net Profit of Suven Life Sciences Ltd

No data available

* All values are in crore

Suven Life Sciences Ltd News Hub

News

Suven Life Sciences announces board meeting date

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 Oct...

Read more

21 Oct 202417:47

News

Suven Life hits lower circuit as Q1 net loss widens to Rs 28 cr

Consolidated net sales slipped 73.42% year on year (YoY) to Rs 1.01 crore in the quarter e...

Read more

05 Aug 202414:00

News

Suven Life Sciences announces board meeting date

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 5 Augu...

Read more

30 Jul 202410:24

News

Suven Life Sciences to convene AGM

Suven Life Sciences announced that the 35th Annual General Meeting(AGM) of the company wil...

Read more

07 May 202412:58

News

Suven Life Sciences to announce Quarterly Result

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 6 May ...

Read more

29 Apr 202419:07

News

Suven Life Sciences to hold board meeting

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 30 Jan...

Read more

24 Jan 202413:53

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Suven Life Sciences Ltd Quarterly Result

What is the EPS of Suven Life Sciences Ltd stock?

The Earnings Per Share (EPS) of Suven Life Sciences Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Suven Life Sciences Ltd EPS calculated?

The EPS of Suven Life Sciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Suven Life Sciences Ltd report its EPS?

Suven Life Sciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Suven Life Sciences Ltd EPS?

Factors that influence the EPS of Suven Life Sciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Suven Life Sciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Suven Life Sciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*